Hwang J - Search Results

1

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.

Ko AH, Venook AP, Bergsland EK, Kelley RK, Korn WM, Dito E, Schillinger B, Scott J, Hwang J, Tempero MA. Ko AH, et al. Among authors: hwang j. Cancer Chemother Pharmacol. 2010 Nov;66(6):1051-7. doi: 10.1007/s00280-010-1257-5. Epub 2010 Feb 4. Cancer Chemother Pharmacol. 2010. PMID: 20130876 Clinical Trial.

2

CA 19-9 Response: A Surrogate to Predict Survival in Patients With Metastatic Pancreatic Adenocarcinoma.

Diaz CL, Cinar P, Hwang J, Ko AH, Tempero MA. Diaz CL, et al. Among authors: hwang j. Am J Clin Oncol. 2019 Dec;42(12):898-902. doi: 10.1097/COC.0000000000000620. Am J Clin Oncol. 2019. PMID: 31634155

3

A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?

Ko AH, Dito E, Schillinger B, Venook AP, Xu Z, Bergsland EK, Wong D, Scott J, Hwang J, Tempero MA. Ko AH, et al. Among authors: hwang j. Invest New Drugs. 2008 Oct;26(5):463-71. doi: 10.1007/s10637-008-9127-2. Epub 2008 Apr 1. Invest New Drugs. 2008. PMID: 18379729 Clinical Trial.

4

Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy.

Wong D, Ko AH, Hwang J, Venook AP, Bergsland EK, Tempero MA. Wong D, et al. Among authors: hwang j. Pancreas. 2008 Oct;37(3):269-74. doi: 10.1097/MPA.0b013e31816d8185. Pancreas. 2008. PMID: 18815548

5

Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II Trials.

Kunz PL, Balise RR, Fehrenbacher L, Pan M, Venook AP, Fisher GA, Tempero MA, Ko AH, Korn WM, Hwang J, Bergsland EK. Kunz PL, et al. Among authors: hwang j. Pancreas. 2016 Nov;45(10):1394-1400. doi: 10.1097/MPA.0000000000000659. Pancreas. 2016. PMID: 27171514 Clinical Trial.

6

Alternate Week Gemcitabine and Capecitabine: An Effective Treatment for Patients With Pancreatic Adenocarcinoma.

Johns C, Diaz CL, Hwang J, Kerridge WD, Ko AH, Tempero MA. Johns C, et al. Among authors: hwang j. Pancreas. 2019 Aug;48(7):927-930. doi: 10.1097/MPA.0000000000001354. Pancreas. 2019. PMID: 31268983

7

Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.

Kelley RK, Joseph NM, Nimeiri HS, Hwang J, Kulik LM, Ngo Z, Behr SC, Onodera C, Zhang K, Bocobo AG, Benson AB, Venook AP, Gordan JD. Kelley RK, et al. Among authors: hwang j. Liver Cancer. 2021 Sep 6;10(6):561-571. doi: 10.1159/000518297. eCollection 2021 Nov. Liver Cancer. 2021. PMID: 34950179 Free PMC article.

8

Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.

Kelley RK, Magbanua MJ, Butler TM, Collisson EA, Hwang J, Sidiropoulos N, Evason K, McWhirter RM, Hameed B, Wayne EM, Yao FY, Venook AP, Park JW. Kelley RK, et al. Among authors: hwang j. BMC Cancer. 2015 Mar 31;15:206. doi: 10.1186/s12885-015-1195-z. BMC Cancer. 2015. PMID: 25884197 Free PMC article.

9

A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy.

Pishvaian MJ, Slack R, Koh EY, Beumer JH, Hartley ML, Cotarla I, Deeken J, He AR, Hwang J, Malik S, Firozvi K, Liu M, Elston B, Strychor S, Egorin MJ, Marshall JL. Pishvaian MJ, et al. Among authors: hwang j. Cancer Chemother Pharmacol. 2012 Dec;70(6):843-53. doi: 10.1007/s00280-012-1969-9. Epub 2012 Sep 27. Cancer Chemother Pharmacol. 2012. PMID: 23014737 Free PMC article. Clinical Trial.

10

Open-label phase 1b study of FOLFIRI plus cetuximab plus IMO-2055 in patients with colorectal cancer who have progressed following chemotherapy for advanced or metastatic disease.

Chan E, Kwak EL, Hwang J, Heiskala M, de La Bourdonnaye G, Mita M. Chan E, et al. Among authors: hwang j. Cancer Chemother Pharmacol. 2015 Apr;75(4):701-9. doi: 10.1007/s00280-015-2682-2. Epub 2015 Jan 28. Cancer Chemother Pharmacol. 2015. PMID: 25627002 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,690 results

Search Page

Filters